The United Laboratories International Holdings Limited
ULIHF
$1.64
-$0.1543-8.60%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 369.65M | 386.56M | 402.77M | 391.45M | 381.45M |
| Total Depreciation and Amortization | 83.10M | 79.86M | 76.47M | 77.02M | 77.91M |
| Total Amortization of Deferred Charges | 2.48M | 2.33M | 2.18M | 2.18M | 2.18M |
| Total Other Non-Cash Items | -26.62M | -6.52M | 13.66M | 12.30M | 10.98M |
| Change in Net Operating Assets | 16.00M | -25.71M | -67.37M | -97.22M | -127.82M |
| Cash from Operations | 444.61M | 436.52M | 427.71M | 385.72M | 344.70M |
| Capital Expenditure | -238.50M | -229.15M | -219.31M | -199.05M | -179.13M |
| Sale of Property, Plant, and Equipment | 1.32M | 927.20K | 526.60K | 570.70K | 617.70K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.29M | -9.93M | -16.39M | -27.76M | -39.13M |
| Cash from Investing | -240.47M | -238.14M | -235.16M | -226.23M | -217.65M |
| Total Debt Issued | 2.23B | 2.05B | 1.87B | 1.96B | 2.04B |
| Total Debt Repaid | -591.41M | -735.78M | -880.16M | -1.83B | -2.78B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -36.47M | -18.23M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -111.41M | -88.55M | -65.33M | -65.33M | -65.33M |
| Other Financing Activities | -203.30M | -148.94M | -94.58M | -122.95M | -151.32M |
| Cash from Financing | 82.54M | 70.55M | 58.81M | -66.33M | -193.45M |
| Foreign Exchange rate Adjustments | -37.60K | -82.90K | -127.60K | -124.00K | -119.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 286.64M | 268.84M | 251.22M | 93.04M | -66.51M |